Search research articles
Contact Us
Filters
Showing results (71-80 of 79) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 79 results.
Journal of Thrombosis and Thrombolysis
|
June 22, 2016
Outcomes associated with observation stays versus inpatient admissions for pulmonary embolism
Erin R Weeda, W Frank Peacock, Gregory J Fermann, et al.
Oncology and Therapy
|
April 4, 2023
Component Costs of CAR-T Therapy in Addition to Treatment Acquisition Costs in Patients with Multiple Myeloma
Sundar Jagannath, Nedra Joseph, Concetta Crivera, et al.
Internal and Emergency Medicine
|
February 11, 2017
External validation of a claims-based and clinical approach for predicting post-pulmonary embolism outcomes among United States veterans
Christine G Kohn, Erin R Weeda, Neela Kumar, et al.
BMC Pulmonary Medicine
|
February 15, 2017
Observation management of pulmonary embolism and agreement with claims-based and clinical risk stratification criteria in United States patients: a retrospective analysis
Elaine Nguyen, Craig I Coleman, W Frank Peacock, et al.
Annals of General Psychiatry
|
April 6, 2011
Effectiveness of injectable risperidone long-acting therapy for schizophrenia: data from the US, Spain, Australia, and Belgium
Tim Lambert, José M Olivares, Joseph Peuskens, et al.
Headache
|
December 7, 2007
The impact of topiramate on health-related quality of life indicators in chronic migraine
David W Dodick, Stephen Silberstein, Joel Saper, et al.
Chest
|
September 12, 2018
Health-care Cost Impact of Continued Anticoagulation With Rivaroxaban vs Aspirin for Prevention of Recurrent Symptomatic VTE in the EINSTEIN-CHOICE Trial Population
Philip S Wells, Martin H Prins, Jan Beyer-Westendorf, et al.
Ejhaem
|
July 18, 2022
Comparative effectiveness of ciltacabtagene autoleucel in CARTITUDE-1 versus physician's choice of therapy in the Flatiron Health multiple myeloma cohort registry for the treatment of patients with relapsed or refractory multiple myeloma
Thomas Martin, Amrita Krishnan, Kwee Yong, et al.
Future Oncology (London, England)
|
May 18, 2022
Process, resource and success factors associated with chimeric antigen receptor T-cell therapy for multiple myeloma
Daanish Hoda, Robert Richards, Edward A Faber, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 79) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 79 results.
Journal of Thrombosis and Thrombolysis
|
June 22, 2016
Outcomes associated with observation stays versus inpatient admissions for pulmonary embolism
Erin R Weeda, W Frank Peacock, Gregory J Fermann, et al.
Oncology and Therapy
|
April 4, 2023
Component Costs of CAR-T Therapy in Addition to Treatment Acquisition Costs in Patients with Multiple Myeloma
Sundar Jagannath, Nedra Joseph, Concetta Crivera, et al.
Internal and Emergency Medicine
|
February 11, 2017
External validation of a claims-based and clinical approach for predicting post-pulmonary embolism outcomes among United States veterans
Christine G Kohn, Erin R Weeda, Neela Kumar, et al.
BMC Pulmonary Medicine
|
February 15, 2017
Observation management of pulmonary embolism and agreement with claims-based and clinical risk stratification criteria in United States patients: a retrospective analysis
Elaine Nguyen, Craig I Coleman, W Frank Peacock, et al.
Annals of General Psychiatry
|
April 6, 2011
Effectiveness of injectable risperidone long-acting therapy for schizophrenia: data from the US, Spain, Australia, and Belgium
Tim Lambert, José M Olivares, Joseph Peuskens, et al.
Headache
|
December 7, 2007
The impact of topiramate on health-related quality of life indicators in chronic migraine
David W Dodick, Stephen Silberstein, Joel Saper, et al.
Chest
|
September 12, 2018
Health-care Cost Impact of Continued Anticoagulation With Rivaroxaban vs Aspirin for Prevention of Recurrent Symptomatic VTE in the EINSTEIN-CHOICE Trial Population
Philip S Wells, Martin H Prins, Jan Beyer-Westendorf, et al.
Ejhaem
|
July 18, 2022
Comparative effectiveness of ciltacabtagene autoleucel in CARTITUDE-1 versus physician's choice of therapy in the Flatiron Health multiple myeloma cohort registry for the treatment of patients with relapsed or refractory multiple myeloma
Thomas Martin, Amrita Krishnan, Kwee Yong, et al.
Future Oncology (London, England)
|
May 18, 2022
Process, resource and success factors associated with chimeric antigen receptor T-cell therapy for multiple myeloma
Daanish Hoda, Robert Richards, Edward A Faber, et al.
Page
of 8